help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, F. A.
Right arrow Articles by Challis, J. R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, F. A.
Right arrow Articles by Challis, J. R. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
*PROGESTERONE
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 2 700-708
Copyright © 2002 by The Endocrine Society


Other Original Articles

Cortisol/Progesterone Antagonism in Regulation of 15-Hydroxysteroid Dehydrogenase Activity and mRNA Levels in Human Chorion and Placental Trophoblast Cells at Term

Falguni A. Patel and John R. G. Challis

Canadian Institutes for Health Research Group in Fetal and Neonatal Health and Development, Departments of Physiology and Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario M5S 1A8, Canada

Address all correspondence and requests for reprints to: Falguni A. Patel, M.D., 1 Kings College Circle, Medical Sciences Building, Room 3344, Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada. E-mail: fal.patel{at}utoronto.ca

Abstract

PGs mediate parturition events. 15-Hydroxyprostaglandin dehydrogenase (PGDH) catalyzes the first step in the metabolism of PGs to render them inactive. We have reported previously that cortisol (F) decreases PGDH activity and progesterone (P4) maintains PGDH in human chorion and placenta at term. To study the interaction of P4 and F on the regulation of PGDH, we treated chorion and placental trophoblast cells in culture with combinations of F, dexamethasone, P4, trilostane, and medroxyprogesterone acetate (MPA). Following a 24-h steroid treatment period and 4-h PGF2{alpha} challenge, culture media and cells were collected for measurement of PGF2{alpha} levels and PGDH mRNA by RIA and Northern blotting analysis. F and dexamethasone decreased PGDH activity and mRNA levels. Exogenous P4 did not significantly alter PGDH activity or mRNA levels; however, MPA significantly stimulated PGDH activity. Trilostane decreased P4 production by more than 90% and also decreased PGDH activity and expression. Coincubation with P4 or MPA reversed trilostane inhibition of PGDH, consistent with a stimulatory role for endogenous P4 on PGDH. MPA significantly reversed F inhibition of PGDH activity and mRNA levels. In the presence of trilostane, P4 at equimolar concentration to F reversed F inhibition of PGDH mRNA levels. These findings suggest that F may be acting as an endogenous inhibitor of P4 action in the regulation of PGDH at term.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M. Parent, E. Madore, L. A MacLaren, and M. A Fortier
15-Hydroxyprostaglandin dehydrogenase in the bovine endometrium during the oestrous cycle and early pregnancy.
Reproduction, March 1, 2006; 131(3): 573 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Duffy, B. L. Dozier, and C. L. Seachord
Prostaglandin Dehydrogenase and Prostaglandin Levels in Periovulatory Follicles: Implications for Control of Primate Ovulation by Prostaglandin E2
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1021 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. J. Jerde, W. S. Mellon, S. M. Fischer, M. Liebert, D. E. Bjorling, and S. Y. Nakada
Suppression of 15-Hydroxyprostaglandin Dehydrogenase Messenger RNA Concentration, Protein Expression, and Enzymatic Activity during Human Ureteral Obstruction
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 398 - 403.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
G. MASTORAKOS and I. ILIAS
Maternal and Fetal Hypothalamic-Pituitary-Adrenal Axes During Pregnancy and Postpartum
Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 136 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society